MAPT and familial Alzheimer disease: It is argued that in the case of familial Alzheimer’s disease (FAD), τ-associated pathology should not be considered a downstream link in the amyloid cascade, and that the development of AD, according to the amyloid cascade hypothesis and in the case of tau-associated pathology, follows two independent pathways.